QCR Holdings Inc: Form 10-Q for the period ended Sep 30, 2025
Filed with the SEC on Nov 7, 2025 and accepted by EDGAR at Nov 7, 2025, 16:11 ET.
Management's discussion and analysis
As filed, 1,635 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
On May 19, 2022, the board of directors of the Company approved a share repurchase program under which the Company is authorized to repurchase, from time to time as the Company deems appropriate, up to 1,500,000 shares of its outstanding common stock, or approximately 10% of the outstanding shares as of December 31, 2021. 115,735 shares of common stock were repurchased under the share repurchase program during the third quarter of 2025. All shares repurchased under the share repurchase program during the third quarter were retired. On October 20, 2025, board of directors of the Company approved a new share repurchase program under which the Company is authorized to repurchase, from time to time as the Company deems appropriate, of up to 1,700,000 shares of its common stock, or approximately 10% of the outstanding shares as of September 30, 2025. The new share repurchase program does not have an expiration date, and replaced the share repurchase program approved in 2022.
| Period | | Total number of shares purchased | | Average price paid per share | | Total number of shares purchased as part of publicly announced plans or programs | | Maximum number of shares that may yet be purchased under the plans or programs | |
|---|---|---|---|---|---|---|---|---|---|
| July 1-31, 2025 | | — | | $- | | 1,539,085 | | 760,915 | |
| August 1-31, 2025 | | 26,200 | | 77.06 | | 1,565,285 | | 734,715 | |
| September 1-30, 2025 | | 89,535 | | 77.85 | | 1,654,820 | | 645,180 | |
Risk factors
As filed, 366 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
There have been no material changes in the risk factors applicable to the Company from those disclosed in Part I, Item 1A., “Risk Factors,” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024. Please refer to that section of the Company’s Form 10-K for disclosures regarding the risks and uncertainties related to the Company’s business.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Income tax | 3 months2025-07-01 to 2025-09-30 | $3.8m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2025-01-01 to 2025-09-30 | $5.7m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2025-07-01 to 2025-09-30 | $36.7m | us-gaap:NetIncomeLoss |
| Net income | 9 months2025-01-01 to 2025-09-30 | $91.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2025-07-01 to 2025-09-30 | $2.16 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2025-01-01 to 2025-09-30 | $5.38 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2025-07-01 to 2025-09-30 | $2.17 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2025-01-01 to 2025-09-30 | $5.41 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2025-07-01 to 2025-09-30 | 17,015,730 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2025-01-01 to 2025-09-30 | 17,011,877 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2025-01-01 to 2025-09-30 | $86.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2025-01-01 to 2025-09-30 | $42.9m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Total assets | At period end2025-09-30 | $9.57bn | us-gaap:Assets |
| Total liabilities | At period end2025-09-30 | $8.48bn | us-gaap:Liabilities |
| Short-term borrowings | At period end2025-09-30 | $2.9m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2025-09-30 | $1.09bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001104659-25-108483. Last ingested by Listed: Nov 6, 2026, 13:15 ET. Listed shows no prices and gives no investment advice.